These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37161682)

  • 1. Antiarrhythmic Effect of Artemisinin in an Ex-vivo Model of Brugada Syndrome Induced by NS5806.
    Jeong HK; Hong SN; Yoon N; Lee KH; Park HW; Cho JG
    Korean Circ J; 2023 Apr; 53(4):239-250. PubMed ID: 37161682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome.
    Szél T; Koncz I; Antzelevitch C
    Heart Rhythm; 2013 Nov; 10(11):1720-7. PubMed ID: 23911896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acacetin suppresses the electrocardiographic and arrhythmic manifestations of the J wave syndromes.
    Di Diego JM; Patocskai B; Barajas-Martinez H; Borbáth V; Ackerman MJ; Burashnikov A; Clatot J; Li GR; Robinson VM; Hu D; Antzelevitch C
    PLoS One; 2020; 15(11):e0242747. PubMed ID: 33232375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome.
    Patocskai B; Yoon N; Antzelevitch C
    JACC Clin Electrophysiol; 2017 Apr; 3(4):353-363. PubMed ID: 28948234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epicardial Substrate as a Target for Radiofrequency Ablation in an Experimental Model of Early Repolarization Syndrome.
    Yoon N; Patocskai B; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2018 Sep; 11(9):e006511. PubMed ID: 30354293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.
    Minoura Y; Di Diego JM; Barajas-Martínez H; Zygmunt AC; Hu D; Sicouri S; Antzelevitch C
    J Cardiovasc Electrophysiol; 2012 Apr; 23(4):423-32. PubMed ID: 22034916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
    Patocskai B; Barajas-Martinez H; Hu D; Gurabi Z; Koncz I; Antzelevitch C
    Heart Rhythm; 2016 Jun; 13(6):1326-34. PubMed ID: 26820510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome.
    Koncz I; Gurabi Z; Patocskai B; Panama BK; Szél T; Hu D; Barajas-Martínez H; Antzelevitch C
    J Mol Cell Cardiol; 2014 Mar; 68():20-8. PubMed ID: 24378566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome.
    Calloe K; Cordeiro JM; Di Diego JM; Hansen RS; Grunnet M; Olesen SP; Antzelevitch C
    Cardiovasc Res; 2009 Mar; 81(4):686-94. PubMed ID: 19073629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying the antiarrhythmic effect of ARumenamide-787 in experimental models of the J wave syndromes and hypothermia.
    Di Diego JM; Barajas-Martinez H; Cox R; Robinson VM; Jung J; Fouda M; Patocskai B; Abdelsayed M; Ruben PC; Antzelevitch C
    PLoS One; 2023; 18(5):e0281977. PubMed ID: 37159454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome.
    Szél T; Antzelevitch C
    J Am Coll Cardiol; 2014 May; 63(19):2037-45. PubMed ID: 24657694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental verification of the value of the T
    Yoon N; Hong SN; Cho JG; Jeong HK; Lee KH; Park HW
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2098-2105. PubMed ID: 31424133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome.
    Minoura Y; Panama BK; Nesterenko VV; Betzenhauser M; Barajas-Martínez H; Hu D; Di Diego JM; Antzelevitch C
    Heart Rhythm; 2013 Jul; 10(7):1054-62. PubMed ID: 23499631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
    Antzelevitch C; Yan GX; Shimizu W
    J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmural conduction time in an early repolarization syndrome model.
    Yoon N; Jeong HK; Lee KH; Park HW; Cho JG
    Exp Ther Med; 2020 Oct; 20(4):3064-3071. PubMed ID: 32855673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brugada syndrome and ischemia-induced ST-segment elevation. Similarities and differences.
    Di Diego JM; Fish JM; Antzelevitch C
    J Electrocardiol; 2005 Oct; 38(4 Suppl):14-7. PubMed ID: 16226068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome.
    Morita H; Zipes DP; Morita ST; Wu J
    Heart Rhythm; 2007 Jan; 4(1):66-74. PubMed ID: 17198993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brugada syndrome: insights of ST elevation, arrhythmogenicity, and risk stratification from experimental observations.
    Morita H; Zipes DP; Wu J
    Heart Rhythm; 2009 Nov; 6(11 Suppl):S34-43. PubMed ID: 19880072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature modulation of ventricular arrhythmogenicity in a canine tissue model of Brugada syndrome.
    Morita H; Zipes DP; Morita ST; Wu J
    Heart Rhythm; 2007 Feb; 4(2):188-97. PubMed ID: 17275755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine model of Brugada syndrome using regional epicardial cooling of the right ventricular outflow tract.
    Nishida K; Fujiki A; Mizumaki K; Sakabe M; Sugao M; Tsuneda T; Inoue H
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):936-41. PubMed ID: 15333091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.